fibrinogen has been researched along with Agnogenic Myeloid Metaplasia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (78.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boinska, J; Gadomska, G; Jachalska, A; Michalska, M; Rość, D; Ślusarz, R; Stankowska, K; Tylicka, M | 1 |
| Antmen, B; Ergin, M; Kilinc, Y; Leblebisatan, G; Sasmaz, I | 1 |
| ANDERSSON, L; LINDSTEDT, E | 1 |
| DE VRIES, SI; DIK, HJ; MORIAU, M | 1 |
| RIECHE, K | 1 |
| Cramer, EM; Drouin, A; Guichard, J; Jouault, H; Schmitt, A; Wendling, F | 1 |
| Blanco, A; Dupont, J; Fernandez, J; Lazzari, MA; Maugeri, N; Meschengieser, S; Woods, A | 1 |
| Brenner, B; Tatarsky, I; Tavori, S | 1 |
| Brodsky, I; Kahn, SB; Petkov, G; Ross, EM | 2 |
| Brodsky, I | 1 |
| Mardiney, MR; Markham, RV; Sutherland, JC | 1 |
| Holburn, RR; Martinez, J; Shapiro, SS | 1 |
| Gormsen, J; Laursen, B | 1 |
14 other study(ies) available for fibrinogen and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
VEGF-A, sVEGFR-1, and sVEGFR-2 in BCR-ABL negative myeloproliferative neoplasms.
Topics: Aged; Blood Cell Count; Bone Marrow; DNA Mutational Analysis; Female; Fibrinogen; Fusion Proteins, bcr-abl; Humans; Male; Middle Aged; Neovascularization, Pathologic; Polycythemia Vera; Primary Myelofibrosis; Statistics, Nonparametric; Thrombocythemia, Essential; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
Concomitance of idiopathic myelofibrosis and amyloidosis.
Topics: Amyloidosis; Bone Marrow; Child; Fibrinogen; Humans; Kidney; Male; Primary Myelofibrosis; Proteinuria | 2010 |
FIBRINOLYSIS AND BLEEDING FOLLOWING APPENDECTOMY.
Topics: Aminocaproates; Aminocaproic Acid; Appendectomy; Blood Coagulation Tests; Blood Transfusion; Dosage Forms; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Postoperative Complications; Primary Myelofibrosis | 1963 |
[FIBRINOLYSIS INHIBITORS AND DETERMINATION OF PHYSIOLOGICAL AND PATHOLOGICAL ANTIPLASMIN ACTIVITY].
Topics: Antifibrinolytic Agents; Blood Platelet Disorders; Blood Protein Electrophoresis; Deoxyribonuclease I; Enzyme Inhibitors; Fibrinogen; Fibrinolysin; Fibrinolysis; gamma-Globulins; Glycine max; Polycythemia; Primary Myelofibrosis; Serum Globulins; Streptodornase and Streptokinase; Streptokinase; Thrombin; Trypsin | 1964 |
[DATA TO THE DIAGNOSTIC VALUE OF FIBRINOGEN DETERMINATION IN MALIGNANT DISEASES].
Topics: Cyclophosphamide; Fibrinogen; Hodgkin Disease; Humans; Metaplasia; Myeloproliferative Disorders; Neoplasms; Prednisone; Primary Myelofibrosis; Silicotuberculosis; Splenic Diseases | 1964 |
Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis.
Topics: Animals; Cell Communication; Cytoplasmic Granules; Fibrinogen; Fibroblasts; Humans; Integrins; Megakaryocytes; Mice; Microscopy, Immunoelectron; Neutrophils; P-Selectin; Primary Myelofibrosis; Transforming Growth Factor beta; von Willebrand Factor | 2000 |
Intraplatelet levels of vWF:Ag and fibrinogen in myeloproliferative disorders.
Topics: Antigens; Blood Platelets; Fibrinogen; Humans; Leukemia, Myeloid; Myeloproliferative Disorders; Polycythemia Vera; Primary Myelofibrosis; Reference Values; Thrombocythemia, Essential; von Willebrand Factor | 1987 |
Influence of splenectomy on hemostasis in agnogenic myeloid metaplasia.
Topics: Adult; Aged; Blood Coagulation Tests; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Count; Primary Myelofibrosis; Retrospective Studies; Splenectomy | 1987 |
Platelet and fibrinogen kinetics with ( 75 Se)-selenomethionine in patients with myeloproliferative disorders.
Topics: Adult; Aged; Blood Cell Count; Blood Platelets; Cell Survival; Female; Fibrinogen; Hematopoiesis; Humans; Kinetics; Leukemia, Myeloid; Male; Methionine; Middle Aged; Myeloproliferative Disorders; Primary Myelofibrosis; Radioisotopes; Selenium; Splenectomy; Thrombocytopenia | 1972 |
Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
Topics: Blood Cell Count; Blood Platelets; Cell Aggregation; Cell Survival; Fibrinogen; Hemorrhagic Disorders; Humans; Kinetics; Leukemia, Myeloid; Myeloproliferative Disorders; Platelet Adhesiveness; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Thrombocytosis | 1972 |
Leukemia and the hypercoagulable state. Pathogenic and therapeutic implications.
Topics: Anticoagulants; Antineoplastic Agents; Asparaginase; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Disseminated Intravascular Coagulation; Fibrinogen; Hemostasis; Heparin; Humans; Kinetics; Leukemia; Leukemia, Myeloid; Polycythemia Vera; Primary Myelofibrosis; Thrombocytosis | 1974 |
Subclinical immune complexes in the glomeruli of kidneys postmortem.
Topics: Antigen-Antibody Complex; Autopsy; Basement Membrane; Capillaries; Complement System Proteins; Fibrinogen; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Kidney Glomerulus; Leukemia; Leukemia, Myeloid; Lymphoma; Microscopy, Electron; Neoplasms; Primary Myelofibrosis | 1974 |
Metabolism of human prothrombin and fibrinogen in patients with thrombocytosis secondary to myeloproliferative states.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Blood Cell Count; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Busulfan; Fibrinogen; Hematocrit; Humans; Iodine Isotopes; Leukocytes; Middle Aged; Myeloproliferative Disorders; Polycythemia Vera; Primary Myelofibrosis; Prothrombin; Splenomegaly; Thrombocythemia, Essential; Thrombocytosis | 1973 |
Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
Topics: Adolescent; Adult; Aged; Aminocaproates; Anticholesteremic Agents; Arteriosclerosis; Arthritis, Rheumatoid; Asthma; Clofibrate; Diabetes Mellitus; Female; Fibrinogen; Fibrinolysis; Humans; Hypoglycemic Agents; Immunoassay; Intermittent Claudication; Kidney Failure, Chronic; Liver Cirrhosis; Lung Neoplasms; Male; Metformin; Middle Aged; Neoplasm Metastasis; Nicotinic Acids; Phlebitis; Physical Exertion; Plasminogen; Primary Myelofibrosis; Propionates; Pulmonary Heart Disease; Testosterone; Tolazamide; Urea | 1969 |